Update on gastric lymphoma.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Primary gastrointestinal lymphoma is an uncommon entity that can often present like classic adenocarcinoma. The most common organ site involved is the stomach. Important prognostic indicators include location of lymph node involvement, histologic subtype, lymphocyte lineage, gross size, and location of the tumor. Surgical resection is the mainstay of curative therapy. Combination chemotherapy and radiotherapy may have a role either separately or as part of a multimodality treatment program. Clinicians are encouraged to enter patients with primary gastric lymphoma into multi-institutional, cooperative group clinical trials to more clearly define the best treatment strategy.

Original languageEnglish (US)
Pages (from-to)713-718
Number of pages6
JournalJournal of the National Medical Association
Volume83
Issue number8
StatePublished - Aug 1991
Externally publishedYes

Fingerprint

Combination Drug Therapy
Lymphoma
Stomach
Adenocarcinoma
Radiotherapy
Therapeutics
Lymph Nodes
Clinical Trials
Lymphocytes
Familial primary gastric lymphoma
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Update on gastric lymphoma. / Thomas, Charles.

In: Journal of the National Medical Association, Vol. 83, No. 8, 08.1991, p. 713-718.

Research output: Contribution to journalArticle

@article{0dc53bc785ad41998b06389d775da044,
title = "Update on gastric lymphoma.",
abstract = "Primary gastrointestinal lymphoma is an uncommon entity that can often present like classic adenocarcinoma. The most common organ site involved is the stomach. Important prognostic indicators include location of lymph node involvement, histologic subtype, lymphocyte lineage, gross size, and location of the tumor. Surgical resection is the mainstay of curative therapy. Combination chemotherapy and radiotherapy may have a role either separately or as part of a multimodality treatment program. Clinicians are encouraged to enter patients with primary gastric lymphoma into multi-institutional, cooperative group clinical trials to more clearly define the best treatment strategy.",
author = "Charles Thomas",
year = "1991",
month = "8",
language = "English (US)",
volume = "83",
pages = "713--718",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "8",

}

TY - JOUR

T1 - Update on gastric lymphoma.

AU - Thomas, Charles

PY - 1991/8

Y1 - 1991/8

N2 - Primary gastrointestinal lymphoma is an uncommon entity that can often present like classic adenocarcinoma. The most common organ site involved is the stomach. Important prognostic indicators include location of lymph node involvement, histologic subtype, lymphocyte lineage, gross size, and location of the tumor. Surgical resection is the mainstay of curative therapy. Combination chemotherapy and radiotherapy may have a role either separately or as part of a multimodality treatment program. Clinicians are encouraged to enter patients with primary gastric lymphoma into multi-institutional, cooperative group clinical trials to more clearly define the best treatment strategy.

AB - Primary gastrointestinal lymphoma is an uncommon entity that can often present like classic adenocarcinoma. The most common organ site involved is the stomach. Important prognostic indicators include location of lymph node involvement, histologic subtype, lymphocyte lineage, gross size, and location of the tumor. Surgical resection is the mainstay of curative therapy. Combination chemotherapy and radiotherapy may have a role either separately or as part of a multimodality treatment program. Clinicians are encouraged to enter patients with primary gastric lymphoma into multi-institutional, cooperative group clinical trials to more clearly define the best treatment strategy.

UR - http://www.scopus.com/inward/record.url?scp=0026211534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026211534&partnerID=8YFLogxK

M3 - Article

C2 - 1956083

AN - SCOPUS:0026211534

VL - 83

SP - 713

EP - 718

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 8

ER -